ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 150311 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 150311; 2) Community: the network communities that were significantly associated with the response to NSC 150311; 3) Molecule: the relationships between components within communities and NSC 150311; 4) MDR: the compounds that were significantly associated with the NSC 150311.

NSC Compound Enrichment Correlation
NSC 680553 2-Quinoxalinecarboxylic acid, 3-[(4-fluorophenyl)amino]-, ethyl ester 0.0107933723273943 -0.4415624
NSC 710598 Null 0.0107933723273943 -0.34194459
NSC 8120 Claviform 0.0107933723273943 0.61115248
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0112113991710615 0.40421614
NSC 176503 Fastigilin B 0.0112113991710615 0.63889314
NSC 180973 Tamoxifen citrate 0.0112113991710615 0.26898464
NSC 295501 Camptothecin Derivative 0.0112113991710615 0.073444791
NSC 299934 THAPSIA VILLOSA COMPD 0.0112113991710615 0.10423172
NSC 362453 Butanedioic acid, mono[2-[3,4-bis(4-chlorophenyl)-5-cyano-6-oxo-1(6H)-pyridazinyl]ethyl] ester 0.0112113991710615 0.23277303
NSC 401268 Bergaptenquinone 0.0112113991710615 0.61941651
Total:119  Current:35    [First] [Prev] [Next] [Last]